◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items
Oncolys BioPharma Inc. — Financial Statements
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line ItemQ3 2025Aug 08, 2025Q4 2024Dec 31, 2024Q3 2024Aug 27, 2024Q3 2024Aug 09, 2024Q4 2023Dec 31, 2023
+Operating Income -793.4M -- -901.0M -901.0M --
Operating Margin % 105.4% -- 103.9% 103.9% --
+Ordinary Income -753.0M -- -867.4M -867.4M --
Revenue Growth % -- -- 0.0% -- --
Line ItemQ3 2025Aug 08, 2025Q4 2024Dec 31, 2024Q3 2024Aug 27, 2024Q3 2024Aug 09, 2024Q4 2023Dec 31, 2023
Current Assets 3.1B -- 2.0B 2.0B --
Total Assets 3.2B 2.1B 2.0B 2.0B 2.3B
Current Liabilities 252.4M -- 378.5M 378.5M --
Total Liabilities 446.6M 395.6M 566.5M 566.5M 445.2M
Total Equity 2.8B 1.7B 1.5B 1.5B 1.8B
Equity Ratio -- 0.81 -- -- 0.80
No data available for this statement.
NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...